Ads
related to: vaccine
Search results
An mRNA Melanoma Vaccine Shows Promise
Time Magazine· 2 hours agoModerna says the same mRNA technology that fueled its COVID-19 vaccine is proving effective in fighting melanoma. The company presented the latest...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 1 hour agoModerna and Merck released more positive three-year data Monday on their experimental vaccine, given...
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Reuters via Yahoo News· 2 hours agoDetailed data on Monday from the 157-patient trial showed that after two and a half years, melanoma...
FDA approves Moderna’s mRNA RSV vaccine for older adults
CNN via Yahoo News· 3 days agoThe US Food and Drug Administration has approved another vaccine that can help protect older people...
FDA approves Moderna’s RSV vaccine mRESVIA
Pharmaceutical Technology via Yahoo Finance· 6 hours agoModerna has secured approval from the US Food and Drug Administration (FDA) for its mRNA-based respiratory syncytial virus (RSV) vaccine mRESVIA...
COVID shots should target JN.1, KP.2 subvariants in 2024-25 campaign, US FDA staff says
Reuters via AOL· 1 hour agoThe FDA reviewers said since the difference between JN.1 and newer subvariants such as KP.2...
U.S. Will Make Millions of Bird Flu Vaccines This Summer | FOX 28 Spokane
FOX 28 Spokane· 2 hours agoAs the H5N1 avian flu continues to spread among dairy cows in the United States, nearly 5 million...
Moderna Investors Just Got Some Bullish News
The Motley Fool via AOL· 5 hours agoModerna (NASDAQ: MRNA) jumped into the limelight when it started developing a coronavirus vaccine candidate. And the stock soared as the vaccine raced...
ASCO: After Keytruda, Merck builds 3-pronged cancer strategy starring Moderna-partnered vaccine
FierceBiotech· 2 hours agoAs Keytruda’s 2028 patent cliff looms large, Merck & Co.’s renewed R&D oncology strategy focuses on...
Is Moderna Stock a Buy Now That It's a 2-Product Company?
Motley Fool via Yahoo Finance· 4 hours agoThe shortened trading week that ended on May 31 was a strange one for the vaccine developer Moderna...
